NCT01473147View on ClinicalTrials.gov

Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patients

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Exenatide

Exenatide 5 microgram bid sc.

DRUG

Normal saline

Normal saline 2 u bid sc.

Trial Locations (1)

333

Chang Gung Memorial Hospital, Taoyuan District

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT01473147 - Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patients | Biotech Hunter | Biotech Hunter